OSTUZZI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.909
EU - Europa 1.639
AS - Asia 648
AF - Africa 6
OC - Oceania 4
SA - Sud America 4
Totale 4.210
Nazione #
US - Stati Uniti d'America 1.876
GB - Regno Unito 429
CN - Cina 408
IT - Italia 284
IE - Irlanda 175
SE - Svezia 175
FR - Francia 161
RU - Federazione Russa 150
DE - Germania 101
SG - Singapore 100
VN - Vietnam 73
FI - Finlandia 69
CA - Canada 30
UA - Ucraina 30
IN - India 20
BE - Belgio 14
ES - Italia 10
NL - Olanda 9
HK - Hong Kong 6
KR - Corea 6
DK - Danimarca 5
JP - Giappone 5
TR - Turchia 5
TW - Taiwan 5
ZA - Sudafrica 5
GR - Grecia 4
IL - Israele 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
SK - Slovacchia (Repubblica Slovacca) 3
AR - Argentina 2
AT - Austria 2
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
IS - Islanda 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
AZ - Azerbaigian 1
EG - Egitto 1
ID - Indonesia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MX - Messico 1
PA - Panama 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 4.210
Città #
Chandler 411
Southend 397
Dublin 160
Ashburn 124
Houston 119
Beijing 118
Jacksonville 114
Verona 107
New York 79
Woodbridge 73
Lawrence 64
Princeton 64
Ann Arbor 62
Wilmington 62
Singapore 58
Dong Ket 41
Helsinki 36
Boardman 33
Jinan 31
Seattle 31
Kent 27
Nanjing 27
Sindelfingen 26
Dallas 23
Redwood City 21
Shenyang 21
Dearborn 19
Washington 19
Los Angeles 18
Zhengzhou 17
Toronto 16
Chicago 15
Hebei 14
Redmond 14
Brussels 13
Haikou 13
Nanchang 12
Jiaxing 11
Ningbo 11
Norwalk 11
Buffalo 9
Düsseldorf 9
Roverbella 9
Tianjin 9
Guangzhou 8
Milan 8
San Francisco 8
Taizhou 8
Hangzhou 7
Saint Petersburg 7
Changsha 6
Falls Church 6
Giugliano In Campania 6
Miami 6
Rome 6
Seoul 6
Taiyuan 6
Fairfield 5
Henderson 5
Mumbai 5
Padova 5
Portland 5
San Antonio 5
Amsterdam 4
Cagliari 4
Clifton Park 4
Fort Worth 4
Istanbul 4
Lanzhou 4
Lappeenranta 4
Manchester 4
Noordwyk 4
Paris 4
Tampa 4
Aosta 3
Bologna 3
Brooklyn 3
Coimbatore 3
Dundas 3
Florence 3
Frankfurt am Main 3
Fuzhou 3
Gabriola 3
Kochi 3
Lombard 3
Mungia 3
Pieve di Soligo 3
Taipei 3
Tokyo 3
Atlanta 2
Baltimore 2
Belleville 2
Bend 2
Bielefeld 2
Biratnagar 2
Bratislava 2
Brent 2
Brno 2
Buenos Aires 2
Cascina 2
Totale 2.797
Nome #
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis 298
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies 109
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare 106
Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective. 96
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 93
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature 89
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval 88
Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis 86
First-generation antipsychotics and QTc: any role for mediating variables? 84
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 82
Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study 75
Antipsychotic drug exposure and risk of myocardial infarction 74
Implementation of treatment guidelines for specialist mental health care 74
Beneficial and harmful consequences of prepartum and postpartum antidepressant exposure 73
Long-acting antipsychotics: patient’s features and prescribing attitudes in Italy. Findings from the cross-sectional phase of an observational, longitudinal, multicenter study. 73
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies 72
Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies 72
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis 71
Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials 71
Antidepressants for the treatment of depression in people with cancer 70
Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised study 70
Antipsychotic combinations in schizophrenia 69
Can we identify the active ingredients of behaviour change interventions for coronary heart disease patients? A systematic review and meta-analysis 68
Public health psychopharmacology: a new research discipline comes of age? 68
Efficacy of psychosocial interventions for mental health outcomes in low-income and middle-income countries: an umbrella review 67
A network meta-analysis of psychosocial interventions for refugees and asylum seekers with PTSD 66
Can a digital medicine system improve adherence to antipsychotic treatment? 65
Autism spectrum disorders: weighing the risk of SSRI exposure in pregnancy 62
Esketamine for treatment resistant depression: a trick of smoke and mirrors? 62
Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial 62
Regulatory meta-analyses for the evaluation of psychotropic medicines 59
New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base 57
Prevalence and Correlates of Psychological Distress and Psychiatric Disorders in Asylum Seekers and Refugees Resettled in an Italian Catchment Area 57
Comparing long-acting antipsychotic discontinuation rates under ordinary clinical circumstances: a survival analysis from an observational, pragmatic study 57
Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance 56
SSRI plus supportive care more effective than supportive care alone for mild to moderate depression 55
Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysis 53
Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies 53
Vortioxetine for depression in adults 52
Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study 51
Effectiveness of a stepped-care programme of WHO psychological interventions in migrant populations resettled in Italy: study protocol for the RESPOND randomized controlled trial 50
Medicine-based evidence: the case of antidepressants in patients with coronary artery disease 50
Effectiveness of Self-Help Plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial 50
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants 50
Efficacy of interventions to reduce coercive treatment in mental health services: umbrella review of randomised evidence 48
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries 48
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis 45
Esketamine clinical trials: reply to Maju et al 45
Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study 43
Introduction and methods of the evidence-based guidelines for the diagnosis and management of autism spectrum disorder by the Italian National Institute of Health 42
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations 42
Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials 42
Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial 41
Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders: findings from the STAR Network Depot Study 39
Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD) 34
Cost-effectiveness of the Self-Help Plus Intervention for Adult Syrian Refugees Hosted in Turkey 34
Effectiveness of a WHO self-help psychological intervention for preventing mental disorders among Syrian refugees in Turkey: a randomized controlled trial 33
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches 31
Umbrella systematic review and meta-analysis: physical activity as an effective therapeutic strategy for improving psychosocial outcomes in children and adolescents 30
The role of attitudes toward medication and treatment adherence in the clinical response to LAIs: findings from the STAR Network Depot Study 27
Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses 24
Expanding access to long-acting antipsychotics in low-income and middle-income countries 24
CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials 22
Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries 22
Factors associated with medication adherence to long-acting injectable antipsychotics: results from the STAR Network Depot Study 22
Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study 21
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review 20
Withdrawal syndrome following discontinuation of 28 antidepressants: pharmacovigilance analysis of 31,688 reports from the WHO spontaneous reporting database 20
Antidepressants for the treatment of depression in people with cancer 20
Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study 18
Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations 18
An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders 17
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study 17
Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database 17
Risk factors for mental disorder development in asylum seekers and refugees resettled in Western Europe and Turkey: Participant-level analysis of two large prevention studies 17
Preventing relapse in schizophrenia needs better evidence 17
Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level 17
Updating the WHO Model Lists of Essential Medicines to promote global access to the most cost-effective and safe medicines for mental disorders 17
Crossroads of methodological choices in research synthesis: insights from two network meta-analyses on preventing relapse in schizophrenia 15
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 14
Ground-breaking change to the mental health section of the WHO Model List of Essential Medicines: implications for low- and middle-income countries 13
Association between adverse childhood experiences and suicidal behavior in schizophrenia spectrum disorders: A systematic review and meta-analysis 13
Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions? 11
Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis 9
Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials 9
Treatment of locally advanced rectal cancer in the era of total neoadjuvant therapy: a systematic review and network meta-analysis 8
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicines 7
Combining randomised and observational evidence in schizophrenia: how real is the real world? 6
Esketamine for treatment-resistant depression in adults 5
Early pharmacological interventions for prevention of post-traumatic stress disorder (PTSD) in individuals experiencing acute traumatic stress symptoms 3
Totale 4.352
Categoria #
all - tutte 18.318
article - articoli 18.119
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 199
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020317 0 0 3 9 42 71 29 13 22 42 47 39
2020/2021495 50 64 19 62 61 51 15 7 16 27 42 81
2021/2022494 21 76 2 45 66 9 17 35 24 14 52 133
2022/20231.291 73 133 101 202 111 268 33 100 167 30 43 30
2023/2024909 58 69 65 87 109 143 42 67 19 47 117 86
2024/2025205 108 97 0 0 0 0 0 0 0 0 0 0
Totale 4.352